Clinical Outcomes Amongst Patients Infected With Candida Auris: A Single‐Center Study
Clinical cure of invasive C. auris infections was dependent on mycologic cure, length of ICU stays, and baseline CRP levels, with observed 30-day all-cause mortality up to 28.6%. Similarly to other reports, our isolates exhibited resistance to fluconazole and amphotericin B in most cases. Only two isolates demonstrated resistance to caspofungin and were deemed pan-resistant. Further multi-centre studies are needed to validate our findings.
Authors
- Wasim S. El Nekidy (ORCID: https://orcid.org/0000-0003-3109-0590)
- Rania M. El-Lababidi (ORCID: https://orcid.org/0000-0002-8707-6627)
- Claude Afif (ORCID: https://orcid.org/0000-0001-5599-5680)
- Emna Abidi (ORCID: https://orcid.org/0000-0002-6054-1840)
- Sara Al Jabi
Institutions
- Cleveland Clinic (US)
- United Arab Emirates University (AE)
- Cleveland Clinic Lerner College of Medicine (US)
- Abu Dhabi Health Services (AE)
- Case Western Reserve University (US)
Publication Details
- Journal
- Mycoses
- Published
- 2025-04-01
- DOI
- https://doi.org/10.1111/myc.70054
- Citations
- 1
- Primary Topic
- Antifungal resistance and susceptibility
- Type
- article
- Field-Weighted Citation Impact
- 1.40